Starsource Multitrade

Starsource Multitrade Financing Cash Flow

The Net Financing Cash Flow of Starsource Multitrade (506365.BO) as of Oct 27, 2026 is -1.59 M INR. In the previous year, Net Financing Cash Flow was -1.49 M INR — a change of 6.48% (lower).

Financing Cash Flow

-1.59 MINR

YoY

6.48%

Last updated:

Net Financing Cash Flow of Starsource Multitrade is 2025 -1.59 M INR. Net Financing Cash Flow of Starsource Multitrade was 2024 -1.49 M INR. It decreases by 6.48% lower compared to the previous year.

The Starsource Multitrade Financing Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financing Cash Flow
Date
Financing Cash Flow
Jan 1, 2014
-5.00 M INR
Jan 1, 2015
-5.00 M INR
Jan 1, 2016
-5.00 M INR
Jan 1, 2017
-5.00 M INR
Jan 1, 2023
-763,090.00 INR
Jan 1, 2024
-1.49 M INR
Jan 1, 2025
-1.59 M INR
The Starsource Multitrade Financing Cash Flow history
YEARFinancing Cash FlowYoY
-1.59 MINR+6.48%
-1.49 MINR+95.19%
-763,090.00INR-84.74%
-5.00 MINR0.00%
-5.00 MINR0.00%
-5.00 MINR0.00%
-5.00 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Starsource Multitrade Stock analysis

What does Starsource Multitrade do? Starsource Multitrade Ltd focuses on acquiring power and chemicals businesses, having transitioned from its former role as a pharmaceutical company. The company is exploring new business opportunities in the power and chemicals sectors, aiming to expand its portfolio through strategic acquisitions. Chemo Pharma Laboratories Ltd, which was formerly a pharmaceutical company, is now part of this strategic shift, though it has no current operations. The firm targets opportunities in power and chemicals to build its business model. The company's primary revenue stream comes from acquiring and developing power and chemicals businesses, with Chemo Pharma Laboratories Ltd serving as a former entity that has shifted focus. It does not currently operate any pharmaceutical business, instead concentrating on power and chemicals acquisitions. The business model relies on identifying and integrating new acquisitions in the power and chemicals sectors to generate revenue. Starsource Multitrade Ltd is actively seeking to acquire businesses in the power and chemicals sectors, having moved away from its pharmaceutical roots. The firm has no current operations, indicating a focus on future acquisitions rather than existing business activities. Chemo Pharma Laboratories Ltd, once a pharmaceutical company, is now part of the company's strategic repositioning towards power and chemicals. Starsource Multitrade is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Starsource Multitrade stock

Net Financing Cash Flow of Starsource Multitrade is -1.59 M INR in 2025.

Net Financing Cash Flow of Starsource Multitrade changed from -1.49 M INR to -1.59 M INR, representing a 6.48% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Financing Cash Flow Starsource Multitrade since 2006 – with annual values, charts, and detailed analysis.

Financing cash flow measures cash flows from debt issuance/repayment, equity transactions, and dividend payments.

Net Financing Cash Flow's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Financing Cash Flow's Starsource Multitrade historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Starsource Multitrade

All Key Metrics — Starsource Multitrade